Transdermal buprenorphine in children with cancer-related pain.

Giorgio Attinà, Antonio Ruggiero, Palma Maurizi, Annalisa Arlotta, Antonio Chiaretti, Riccardo Riccardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

16 Citazioni (Scopus)


We present three cases of children (aged 3-5 years) in which cancer-related pain was adequately controlled by Transdermal Buprenorphine. The endpoints for evaluating analgesic efficacy consisted of the assessment of pain using a visual scale and the possibility of reducing other pain treatment. Improvement of pain level was demonstrated by the decrease in pain scores, by reduction of the overall amount of medications, especially opioids, and by improvement of uninterrupted sleep. Only limited data is available on the use of Transdermal Buprenorphine in children. In our experience, Transdermal Buprenorphine allowed good analgesia without significant side effects in these three children with cancer-related pain.
Lingua originaleEnglish
pagine (da-a)125-127
Numero di pagine3
Stato di pubblicazionePubblicato - 2009


  • buprenorphine
  • cancer-related pain
  • transdermal


Entra nei temi di ricerca di 'Transdermal buprenorphine in children with cancer-related pain.'. Insieme formano una fingerprint unica.

Cita questo